Disruptions in the sleep architecture and changes in the gut microbiota may interact in OSA-associated hypertension's physiopathology, and the mTOR signaling pathway may also be involved in this critical mechanism. The gene discussed is MTOR; the disease is obstructive sleep apnea syndrome.